CAMBRIDGE - Moderna announced Monday that its combination COVID and flu vaccine showed positive results in a late-stage trial. The Cambridge, Massac

Moderna says its combination COVID and flu vaccine tested better than separate shots

submited by

Style Pass

2024-06-10 23:30:03

CAMBRIDGE - Moderna announced Monday that its combination COVID and flu vaccine showed positive results in a late-stage trial.

The Cambridge, Massachusetts-based biotech company said the mRNA-1083 vaccine produced a higher immune response in older adults than the separate shots that were co-administered in the study.

"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses," Moderna CEO Stephane Bancel said in a statement Monday. "Moderna is the only company with a positive Phase 3 flu and COVID combination vaccine.

The Phase 3 trial involved two groups of about 4,000 adults each. One group consisted of adults between the 50 and 64 years old and the other was just for those above 65. In the older group, the combination vaccine was compared to a higher dose flu shot.

"In both age cohorts, mRNA-1083 also elicited statistically significantly higher immune responses against three influenza virus strains (H1N1, H3N2, and B/Victoria) and against SARS-CoV-2," Moderna reported.